Not a good buy right now: the trend is technically bearish (SMA_200 > SMA_20 > SMA_5) and probabilistic pattern data points to further downside over 1W/1M.
With no Intellectia buy signals today and weakening fundamentals (2025/Q3 YoY declines), the risk/reward favors avoiding or selling into strength rather than buying pre-market around $21.81.
Best near-term setup would require a clear reclaim of ~$22.27 (R1) or a capitulation/hold near ~$20.50 (S1); neither is confirmed pre-market.
Technical Analysis
Price context: Pre-market ~$21.81, slightly above pivot $21.384; overhead resistance at $22.271 (R1) then $22.818 (R2); supports at $20.498 (S1) then $19.951 (S2).
Trend: Bearish moving average stack (SMA_200 > SMA_20 > SMA_5) indicates the broader trend remains down.
Momentum: MACD histogram -0.0842 (below zero) though negatively contracting—bearish momentum is easing, but not reversed.
RSI(6) ~65.7: not oversold; there’s room to fall without becoming “stretched.”
Pattern-based forward bias (similar candlesticks): ~60% chance of -0.37% next day, -5.71% next week, -13.65% next month—skews bearish.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Open interest put/call ratio 1.47 (more puts than calls outstanding) suggests cautious-to-bearish sentiment/hedging.
Activity: Extremely low options volume today (2 total; 0 put volume) limits the strength of any volume-based read.
Volatility: 30D IV ~80.17 vs historical vol ~29.56; IV percentile ~64.94—options are pricing elevated uncertainty relative to realized moves.
Open interest today 153 and “today vs OI avg 30D” ~150 (elevated vs average), but with minimal volume, this looks more like existing positioning than fresh conviction.
Technical Summary
Sell
8
Buy
4
Positive Catalysts
Balance sheet/quality support: cited “zero-debt” profile provides downside support characteristics (analyst noted support near ~$20/share).
MACD downside momentum is contracting (selling pressure may be moderating), which can precede stabilization if price reclaims resistance.
No negative news flow in the past week (absence of fresh headline risk).
Neutral/Negative Catalysts
and recent execution/leadership concerns highlighted by analysts.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $40.48M, down -8.56% YoY (top-line contraction).
Net income: $8.65M, down -45.30% YoY (profitability deterioration).
EPS: $0.35, down -45.31% YoY (earnings power weakening).
Gross margin: 41.84%, down -11.45% YoY (margin compression—unfavorable operating leverage).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: ratings moved more cautious after a Q3 miss.
2025-11-12: B. Riley kept Neutral and cut price target to $21 from $26 (limited near-term upside; operational/market uncertainty; notes downside support near ~$20 due to zero debt/founder track record).
2025-11-11: CJS Securities downgraded to Market Perform from Outperform.
Wall Street pro view (pros): zero-debt balance sheet; perceived downside support near ~$20; founder track record.
Wall Street con view (cons): Q3 miss, executive departures/operational uncertainty, and reduced near-term upside leading to downgrades/target cuts.
Wall Street analysts forecast LEGH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEGH is 24.5 USD with a low forecast of 21 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast LEGH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEGH is 24.5 USD with a low forecast of 21 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 21.180
Low
21
Averages
24.5
High
28
Current: 21.180
Low
21
Averages
24.5
High
28
B. Riley
Neutral
downgrade
$26 -> $21
AI Analysis
2025-11-12
Reason
B. Riley
Price Target
$26 -> $21
AI Analysis
2025-11-12
downgrade
Neutral
Reason
B. Riley lowered the firm's price target on Legacy Housing to $21 from $26 and keeps a Neutral rating on the shares. Legacy Housing's Q3 results missed expectations, prompting the departure of key executives and the return of co-founder Kenneth Shipley to operations, the analyst tells investors in a research note. The stock's zero-debt balance sheet and founder track record provide downside support near $20/share, but limited near-term upside remains amid operational and market uncertainties, B. Riley says.
CJS Securities
Outperform -> Market Perform
downgrade
2025-11-11
Reason
CJS Securities
Price Target
2025-11-11
downgrade
Outperform -> Market Perform
Reason
CJS Securities downgraded Legacy Housing to Market Perform from Outperform following the company's Q3 miss.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LEGH
